Opposite effect of phencyclidine on activity-regulated cytoskeleton-associated protein (Arc) in juvenile and adult limbic rat brain regions

Neurochemistry International

Volumn 56, Issue 2, 2010, Pages 270-275

  Thomsen, Morten S ^a,b   Hansen, Henrik H ^c   Mikkelsen, Jens D ^a  

^a Copenhagen University Hospital ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NEUROSEARCH A S   (Denmark)

Author keywords

Accumbens; Arc; Juvenile; Parvalbumin; Phencyclidine; Prefrontal cortex; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; MESSENGER RNA; PARVALBUMIN; PHENCYCLIDINE;

ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN MATURATION; BRAIN REGION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MODEL; GABAERGIC TRANSMISSION; LIMBIC CORTEX; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA;

ANIMALS; BASE SEQUENCE; CYTOSKELETAL PROTEINS; DNA PROBES; LIMBIC SYSTEM; NERVE TISSUE PROTEINS; PARVALBUMINS; PHENCYCLIDINE; RATS; RATS, WISTAR; RNA, MESSENGER;

ANIMALIA; RATTUS;

EID: 77149124896     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.10.011     Document Type: Article

References (54)

1. Abdel-Naby Sayed M., Noda Y., Mahmoud Hamdy M., Mamiya T., Nagai T., Furukawa H., Nabeshima T. Enhancement of immobility induced by repeated phencyclidine injection: association with c-Fos protein in the mouse brain. Behav. Brain Res. 2001, 124:71-76.
2. Abdul-Monim Z., Neill J.C., Reynolds G.P. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J. Psychopharmacol. 2007, 21:198-205.
3. Behrens M.M., Ali S.S., Dao D.N., Lucero J., Shekhtman G., Quick K.L., Dugan L.L. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 2007, 318:1645-1647.
4. Benes F.M., Taylor J.B., Cunningham M.C. Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: implications for the development of psychopathology. Cereb. Cortex. 2000, 10:1014-1027.
5. Benes F.M., Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25:1-27.
6. Braun I., Genius J., Grunze H., Bender A., Moller H.J., Rujescu D. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr. Res. 2007, 97:254-263.
7. Cardin J.A., Carlen M., Meletis K., Knoblich U., Zhang F., Deisseroth K., Tsai L.H., Moore C.I. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 2009, 459:663-667.
8. Cochran S.M., Kennedy M., McKerchar C.E., Steward L.J., Pratt J.A., Morris B.J. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology 2003, 28:265-275.
9. Coyle J.T. The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochem. Pharmacol. 2004, 68:1507-1514.
10. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol. Neurobiol. 2006, 26:365-384.
11. Cruz D.A., Eggan S.M., Lewis D.A. Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J. Comp. Neurol. 2003, 465:385-400.
12. Davis B.L. The PCP epidemic: a critical review. Int. J. Addict. 1982, 17:1137-1155.
13. Doischer D., Hosp J.A., Yanagawa Y., Obata K., Jonas P., Vida I., Bartos M. Postnatal differentiation of basket cells from slow to fast signaling devices. J. Neurosci. 2008, 28:12956-12968.
14. Goldberg J.H., Yuste R., Tamas G. Ca2+ imaging of mouse neocortical interneurone dendrites: contribution of Ca2+-permeable AMPA and NMDA receptors to subthreshold Ca2+ dynamics. J. Physiol. 2003, 551:67-78.
15. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 1996, 16:2034-2043.
16. Guzowski J.F., Lyford G.L., Stevenson G.D., Houston F.P., McGaugh J.L., Worley P.F., Barnes C.A. Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J. Neurosci. 2000, 20:3993-4001.
17. Guzowski J.F., Timlin J.A., Roysam B., McNaughton B.L., Worley P.F., Barnes C.A. Mapping behaviorally relevant neural circuits with immediate-early gene expression. Curr. Opin. Neurobiol. 2005, 15:599-606.
18. Hashimoto K., Ishima T., Fujita Y., Matsuo M., Kobashi T., Takahagi M., Tsukada H., Iyo M. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711. Biol. Psychiatry 2008.
19. Helmeke C., Ovtscharoff W., Poeggel G., Braun K. Imbalance of immunohistochemically characterized interneuron populations in the adolescent and adult rodent medial prefrontal cortex after repeated exposure to neonatal separation stress. Neuroscience 2008, 152:18-28.
20. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991, 148:1301-1308.
21. Jenkins T.A., Harte M.K., McKibben C.E., Elliott J.J., Reynolds G.P. Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat. Behav. Brain Res. 2008, 194:230-235.
22. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20:201-225.
23. Katayama T., Jodo E., Suzuki Y., Hoshino K.Y., Takeuchi S., Kayama Y. Activation of medial prefrontal cortex neurons by phencyclidine is mediated via AMPA/kainate glutamate receptors in anesthetized rats. Neuroscience 2007, 150:442-448.
24. Kinney J.W., Davis C.N., Tabarean I., Conti B., Bartfai T., Behrens M.M. A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J. Neurosci. 2006, 26:1604-1615.
25. Korenbrot C.C., Huhtaniemi I.T., Weiner R.I. Preputial separation as an external sign of pubertal development in the male rat. Biol. Reprod. 1977, 17:298-303.
26. Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) 2003, 169:215-233.
27. Larsen M.H., Olesen M., Woldbye D.P., Hay-Schmidt A., Hansen H.H., Ronn L.C., Mikkelsen J.D. Regulation of activity-regulated cytoskeleton protein (Arc) mRNA after acute and chronic electroconvulsive stimulation in the rat. Brain Res. 2005, 1064:161-165.
28. Lewis D.A. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 1997, 16:385-398.
29. Lewis D.A., Cruz D., Eggan S., Erickson S. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia. Ann. N. Y. Acad. Sci. 2004, 1021:64-76.
30. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 2005, 6:312-324.
31. Lewis D.A., Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 2008, 33:141-165.
32. Lujan R., Shigemoto R., Lopez-Bendito G. Glutamate and GABA receptor signalling in the developing brain. Neuroscience 2005, 130:567-580.
33. Martinez Z.A., Ellison G.D., Geyer M.A., Swerdlow N.R. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharmacology 1999, 21:28-39.
34. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003, 40:881-884.
35. Morrow B.A., Elsworth J.D., Roth R.H. Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axo-axonic projections in the prefrontal cortex. Psychopharmacology (Berl) 2007, 192:283-290.
36. Mouri A., Noda Y., Enomoto T., Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem. Int. 2007, 51:173-184.
37. Murai R., Noda Y., Matsui K., Kamei H., Mouri A., Matsuba K., Nitta A., Furukawa H., Nabeshima T. Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling. Behav. Brain Res. 2007, 180:152-160.
38. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 1995, 52:998-1007.
39. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press.
40. Paz R.D., Tardito S., Atzori M., Tseng K.Y. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur. Neuropsychopharmacol. 2008, 18:773-786.
41. Pei Q., Zetterström T.S., Sprakes M., Tordera R., Sharp T. Antidepressant drug treatment induces Arc gene expression in the rat brain. Neuroscience 2003, 121:975-982.
42. Plath N., Ohana O., Dammermann B., Errington M.L., Schmitz D., Gross C., Mao X., Engelsberg A., Mahlke C., Welzl H., Kobalz U., Stawrakakis A., Fernandez E., Waltereit R., Bick-Sander A., Therstappen E., Cooke S.F., Blanquet V., Wurst W., Salmen B., Bosl M.R., Lipp H.P., Grant S.G., Bliss T.V., Wolfer D.P., Kuhl D. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 2006, 52:437-444.
43. Pratt J.A., Winchester C., Egerton A., Cochran S.M., Morris B.J. Modelling prefrontal cortex deficits in schizophrenia: implications for treatment. Br. J. Pharmacol. 2008, 153(Suppl. 1):S465-S470.
44. Ragland J.D., Yoon J., Minzenberg M.J., Carter C.S. Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism. Int. Rev. Psychiatry 2007, 19:417-427.
45. Rodefer J.S., Murphy E.R., Baxter M.G. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. Eur. J. Neurosci. 2005, 21:1070-1076.
46. Schochet T.L., Kelley A.E., Landry C.F. Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain. Neuroscience 2005, 135:285-297.
47. Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009, 459:698-702.
48. Sommer B., Keinanen K., Verdoorn T.A., Wisden W., Burnashev N., Herb A., Kohler M., Takagi T., Sakmann B., Seeburg P.H. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 1990, 249:1580-1585.
49. Stine C.D., Lu W., Wolf M.E. Expression of AMPA receptor flip and flop mRNAs in the nucleus accumbens and prefrontal cortex after neonatal ventral hippocampal lesions. Neuropsychopharmacology 2001, 24:253-266.
50. Thomsen M.S., Christensen D.Z., Hansen H.H., Redrobe J.P., Mikkelsen J.D. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 2009, 56:1001-1009.
51. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador-Woodruff J.H., Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 2005, 57:252-260.
52. Tzingounis A.V., Nicoll R.A. Arc/Arg3.1: linking gene expression to synaptic plasticity and memory. Neuron 2006, 52:403-407.
53. Uhlhaas P.J., Roux F., Singer W., Haenschel C., Sireteanu R., Rodriguez E. The development of neural synchrony reflects late maturation and restructuring of functional networks in humans. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9866-9871.
54. Vazdarjanova A., Ramirez-Amaya V., Insel N., Plummer T.K., Rosi S., Chowdhury S., Mikhael D., Worley P.F., Guzowski J.F., Barnes C.A. Spatial exploration induces ARC, a plasticity-related immediate-early gene, only in calcium/calmodulin-dependent protein kinase II-positive principal excitatory and inhibitory neurons of the rat forebrain. J. Comp. Neurol. 2006, 498:317-329.